Inamed Corporation is a healthcare products manufacturer focused on marketing breast implants, dermal fillers to correct facial wrinkles, and devices to treat severe and morbid obesity. The company operates through two divisions: Inamed Aesthetics and Inamed Health. Through Inamed Aesthetics, the company offers a broad range of breast implants that are used for therapeutic purposes in reconstruction surgeries but find their greatest use in breast augmentation procedures. The division also produces a line of dermal fillers, including Reloxin, a botulinum toxin under development that is billed as the company’s competitive answer to Allergan, Inc.’s hugely popular Botox dermal filler. Inamed Health produces products for minimally invasive surgical solutions to obesity, including a device marketed under the name “Lap-Band,” which is a less traumatic alternative to surgeries such as gastric bypass and stomach stapling. Inamed maintains manufacturing facilities in the United States, Costa Rica, and Ireland, marketing its products in more than 50 countries.